How much dividend does ESSA Pharma pay?
Over the past 12 months, ESSA Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, ESSA Pharma is expected to pay a dividend of 0 USD.
ESSA Pharma Dividend 2024
ESSA Pharma Dividend
0 USD
ESSA Pharma Dividend yield
Ticker
EPIX
ISIN
CA29668H7085
WKN
A2JKQ4
How much dividend does ESSA Pharma 2024 pay?
According to the latest status from November 2024, ESSA Pharma paid a total of 0 USD per share in dividends within the last 12 months. With the current ESSA Pharma price of 1.8 USD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.
| = |
Historical ESSA Pharma Dividends
A dividend is paid times per year. Last year, the payout months were and .
| Paydate | Dividend |
|---|
Is the ESSA Pharma Dividend Safe?
ESSA Pharma has been increasing the dividend for 0 years.
Over the past 10 years, ESSA Pharma has increased it by an annual 0 %.
Over a five-year period, the distribution increased by 0%.
Analysts expect a Dividend Cut of -100% for the current fiscal year.
Dividend Details
Understanding ESSA Pharma's Dividend Distributions
ESSA Pharma’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.
Year-to-Year Comparison
Examining ESSA Pharma's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.
Impact on Investments
ESSA Pharma's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.
Interpreting Dividend Fluctuations
Changes in ESSA Pharma’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.
ESSA Pharma Aktienanalyse
What does ESSA Pharma do?
ESSA Pharma Inc is a biopharmaceutical company specializing in the development of therapies for the treatment of prostate cancer and other types of cancer. The company is headquartered in Vancouver, Canada and was founded in 2009. The history of ESSA Pharma Inc begins with the discovery of a new approach to treating prostate cancer by the company's founders. They discovered that a combination of an androgen receptor inhibitor and a NEDDylation signaling inhibitor could offer a new and effective approach to treating prostate cancer. Based on this discovery, they founded ESSA Pharma Inc to further develop this therapy. ESSA Pharma Inc's business model is based on the discovery, development, and commercialization of therapies for the treatment of prostate cancer and other types of cancer. The company has a pipeline of products in various clinical phases aimed at effectively combating prostate cancer and other types of cancer. ESSA Pharma Inc operates in two main divisions: research and development, and marketing and sales. The company's research and development department is dedicated to identifying and developing new compounds tailored to the specific needs of patients with prostate cancer. The company also works closely with researchers and physicians to test the efficacy of its products in treatment protocols and clinical practice. The second division of ESSA Pharma Inc deals with the marketing and sales of its products. Here, the company works closely with pharmaceutical manufacturers and other companies to market and sell its products worldwide. The company also has its own sales department that serves customers worldwide. ESSA Pharma Inc currently offers several products in different stages of clinical trials. These include EPI-506, an androgen receptor inhibitor currently being used in a Phase 1 study for the treatment of prostate cancer, and EPI-7386, a NEDDylation signaling inhibitor currently in a Phase 1 study for the treatment of prostate cancer. In addition, ESSA Pharma Inc has formed partnerships with other companies to further develop its technology platform and pipeline of cancer therapies. For example, the company is collaborating with Bayer Healthcare to advance the development of EPI-7386. Overall, ESSA Pharma Inc is an innovative and emerging biotech company focused on the development of therapies for the treatment of prostate cancer and other types of cancer. The company is pursuing an ambitious strategy and has already achieved promising results in the development of new compounds for the treatment of prostate cancer. ESSA Pharma is one of the most popular companies on Eulerpool.com.Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Frequently Asked Questions about ESSA Pharma stock
What is the dividend yield of ESSA Pharma?
The current dividend yield of ESSA Pharma is .
When does ESSA Pharma pay dividends?
ESSA Pharma pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of ESSA Pharma?
ESSA Pharma paid dividends every year for the past 0 years.
What is the dividend of ESSA Pharma?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is ESSA Pharma located?
ESSA Pharma is assigned to the 'Health' sector.
Wann musste ich die Aktien von ESSA Pharma kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of ESSA Pharma from 11/9/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/9/2024.
When did ESSA Pharma pay the last dividend?
The last dividend was paid out on 11/9/2024.
What was the dividend of ESSA Pharma in the year 2023?
In the year 2023, ESSA Pharma distributed 0 USD as dividends.
In which currency does ESSA Pharma pay out the dividend?
The dividends of ESSA Pharma are distributed in USD.
Andere Kennzahlen von ESSA Pharma
Our stock analysis for ESSA Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ESSA Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
